Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies | Zendy

Jennifer W. Wu | Zendy; Kristian B. Filion | Zendy; Laurent Azoulay | Zendy; Margaret K. Doll | Zendy; Samy Suissa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Long-Acting Insulin Analogs on the Risk of Cancer: A Systematic Review of Observational Studies

Author(s) -

Jennifer W. Wu,

Kristian B. Filion,

Laurent Azoulay,

Margaret K. Doll,

Samy Suissa

Publication year - 2016

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc15-1816

Subject(s) - medicine , observational study , insulin glargine , insulin detemir , incidence (geometry) , cohort study , breast cancer , type 2 diabetes , oncology , insulin , cancer , research design , diabetes mellitus , endocrinology , physics , optics , social science , sociology

Observational studies examining the association between long-acting insulin analogs and cancer incidence have produced inconsistent results. We conducted a systematic review of these studies, focusing on their methodological strengths and weaknesses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research